TOTomoyo Ochiishi

Tomoyo Ochiishi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tomoyo Ochiishi has a total of 124 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Impairment in re-learning of olfactory behaviors in mice expressing intracellular amyloid-β protein oligomers

    by Saya Iwame, Koji Izu, Yoshihiro Murata, Mutsuo Taniguchi, Tomoyo Ochiishi, Masahiro Yamaguchi

    Background: The accumulation of amyloid-β (Aβ) protein is a plausible candidate for the primary cause of Alzheimer's disease (AD). In addition to extracellular deposition, intracellular accumulation of Aβ oligomers is thought to occur during early-stage AD. Considering that olfactory dysfunction is an early event in AD, analyses of intracellular Aβ deposition in the olfactory system could provide insights into disease mechanisms and therapeutic strategies, particularly for early-stage AD. Objective: We examined the olfactory behaviors of transgenic mice expressing intracellular Aβ-green fluorescent protein (GFP) fusion protein oligomers and investigated the manifestation of any abnormalities in mature and young adult stages. Methods: In 6–7-month-old and 2–3-month-old transgenic mice, expression of Aβ-GFP was histologically examined in the fixed brains. The mice's olfactory behaviors including odor detection, odor discrimination and odor-associated learning and memory were examined. Results: Histological analysis confirmed intracellular Aβ-GFP accumulation in brain regions related to olfaction, including the olfactory bulb, olfactory cortex, and orbitofrontal cortex. In 6–7-month-old mice, odor detection and discrimination abilities, as well as odor-reward association learning and long-term memory, were not significantly affected. However, the mice exhibited impaired re-learning of the odor-reward association, in which the initial association of two different odors with or without a sugar reward was subsequently reversed. This behavioral phenotype also was observed in 2–3-month-old mice. Conclusions: These findings indicate that mice expressing intracellular Aβ oligomers experience early-life olfactory disturbances, highlighting their potential utility in studying olfactory dysfunction in early-stage AD.

  • Open Access

    Actin Painting: a multicolor fluorescence staining method highlighting cell type-specific differences in the composition of filamentous actin architectures

    by Akira Nagasaki, Saku T. Kijima, Yoichi Shinkai, Yukio Ohtsuka, Tomoyo Ochiishi, Yasnory T.F. Sasaki, Saori Hata, Kazumi Hirano, Yoshio Kato, Motomichi Doi, et al.

    Actin is a major structural component of the cytoskeleton in eukaryotic cells, and filamentous actin (F-actin) forms a variety of types of cellular structures. Many actin probes have been developed to visualize F-actin architectures in eukaryotic cells. However, it is known that double-stained images of F-actin obtained by two different types of actin probes often show partial inconsistencies. While developing actin probes, we observed that the merged images of three distinct actin probes, each labeled with a different fluorescent dye (red, green and blue), enabled various F-actin architectures to be distinguished based on color. This differentiation arises from slight variations in the distribution of each actin probe, and results in a unique color combination of actin probes that reflects the relative intensities of the three fluorescent dyes. In this report, we introduce a new cell staining method, named Actin Painting, which exploits the unique affinity of actin-binding molecules in each actin probe to F-actin architectures. This technique allows the classification of various cell types based on their specific actin cytoskeleton.


  • Mulberry fruit extract alleviates the intracellular amyloid‐β oligomer‐induced cognitive disturbance and oxidative stress in Alzheimer’s disease model mice

    by Tomoyo Ochiishi, Masami Kaku, Tanwarat Kajsongkram, Krittiya Thisayakorn

    Intracellular amyloid‐β (Aβ) oligomers are key therapeutic targets because they are strongly cytotoxic and play crucial roles in the cognitive function in Alzheimer's disease (AD). Anthocyanins, polyphenolic flavonoids with antioxidant and neuroprotective properties, are potential therapeutic candidates for AD. Here, we investigated the effects of anthocyanin‐enriched extracts from fruits of mulberry (Morus alba Linn.) in Thailand against the neurotoxicity of Aβ oligomers. Using the monitoring system for Aβ aggregation, we showed that the extract induced the dissociation of Aβ in cultured HEK293T cells. To investigate the effects on cognitive function, we orally administered the extract to Aβ‐GFP transgenic mice (Aβ‐GFP Tg), a mouse model that expresses Aβ oligomers inside neurons, and performed the novel object recognition test and passive avoidance test. Aβ‐GFP Tg usually showed deficits in novel object recognition memory and reference memory compared with non‐Tg, but administration of the extract improved both compared with vehicle‐treated Aβ‐GFP Tg. Aβ‐GFP Tg exhibited lower superoxide dismutase (SOD) activity than non‐Tg. However, after the administration of the extract, the SOD activity was restored. These results suggest that Thai mulberry fruit extract ameliorates cytotoxicity induced by the intracellular Aβ oligomers and may be an effective therapeutic or preventive candidate for AD.


  • Open Access

    New Alzheimer’s disease model mouse specialized for analyzing the function and toxicity of intraneuronal Amyloid β oligomers

    by Tomoyo Ochiishi, Masami Kaku, Kazuyuki Kiyosue, Motomichi Doi, Takao Urabe, Nobutaka Hattori, Hideki Shimura, Tatsuhiko Ebihara

    Oligomers of intracellular amyloid β protein (Aβ) are strongly cytotoxic and play crucial roles in synaptic transmission and cognitive function in Alzheimer’s disease (AD). However, there is currently no AD model mouse in which to specifically analyze the function of Aβ oligomers only. We have now developed a novel AD model mouse, an Aβ-GFP transgenic mouse (Aβ-GFP Tg), that expresses the GFP-fused human Aβ1-42 protein, which forms only Aβ oligomers within neurons throughout their life. The fusion proteins are expressed mainly in the hippocampal CA1-CA2 region and cerebral cortex, and are not secreted extracellularly. The Aβ-GFP Tg mice exhibit increased tau phosphorylation, altered spine morphology, decreased expressions of the GluN2B receptor and neuroligin in synaptic regions, attenuated hippocampal long-term potentiation, and impaired object recognition memory compared with non-Tg littermates. Interestingly, these dysfunctions have already appeared in 2–3-months-old animals. The Aβ-GFP fusion protein is bioactive and highly toxic, and induces the similar synaptic dysfunctions as the naturally generated Aβ oligomer derived from postmortem AD patient brains and synthetic Aβ oligomers. Thus, Aβ-GFP Tg mouse is a new tool specialized to analyze the function of Aβ oligomers in vivo and to find subtle changes in synapses in early symptoms of AD.


  • Influence of changes in crystal structures on the luminescent characteristics of GdF3:Tm3+ in a phase separation glass

    by Tetsuro Jin, Tomoyo Ochiishi, Yuri Shibuya, Tetsuo Yazawa

    Hexagonal GdF3:Tm3+, which is thermodynamically unstable at room temperature, was successfully crystallized in borosilicate glass using a phase separation technique. The crystal structure of GdF3 was controlled by the addition of alkaline earth metals to the glass composition. Increasing the amount of SrF2 added to the glass composition to 1.65 mol % increased the amount of precipitation of hexagonal GdF3:Tm3+ crystals and the luminescence intensity. Lanthanide trifluoride phosphors were restrictively obtained in the borate phase as a result, and the emission of Tm3+ at 458 nm was observed. Furthermore, the luminescence intensity of GdF3:Tm3+ in the phase separation glass upon SrF2-doping was about three times larger than that without doping.


  • Open Access

    Development of new fusion proteins for visualizing amyloid-β oligomers in vivo

    by Tomoyo Ochiishi, Motomichi Doi, Kazuhiko Yamasaki, Keiko Hirose, Akira Kitamura, Takao Urabe, Nobutaka Hattori, Masataka Kinjo, Tatsuhiko Ebihara, Hideki Shimura

    The intracellular accumulation of amyloid-β (Aβ) oligomers critically contributes to disease progression in Alzheimer’s disease (AD) and can be the potential target of AD therapy. Direct observation of molecular dynamics of Aβ oligomersin vivois key for drug discovery research, however, it has been challenging because Aβ aggregation inhibits the fluorescence from fusion proteins. Here, we developed Aβ1-42-GFP fusion proteins that are oligomerized and visualize their dynamics inside cells even when aggregated. We examined the aggregation states of Aβ-GFP fusion proteins using several methods and confirmed that they did not assemble into fibrils, but instead formed oligomersin vitroand in live cells. By arranging the length of the liker between Aβ and GFP, we generated two fusion proteins with “a long-linker” and “a short-linker” and revealed that the aggregation property of fusion proteins can be evaluated by measuring fluorescence intensities using rat primary culture neurons transfected with Aβ-GFP plasmids and Aβ-GFP transgenicC. elegans. We found that Aβ-GFP fusion proteins induced cell death in COS7 cells. These results suggested that novel Aβ-GFP fusion proteins could be utilized for studying the physiological functions of Aβ oligomers in living cells and animals and for drug screening by analyzing Aβ toxicity.


  • Open Access

    Immunohistochemical detection of the delayed formation of nonfibrillar large amyloid‐β aggregates

    by Tomoyo Ochiishi, Akira Itakura, Lei Liu, Hiroyasu Akatsu, Hideki Kohno, Masaki Nishimura, Kazuaki Yoshimune

    The occurrence of senile plaques consisting of amyloid‐β protein (Aβ) is a major neuropathological hallmark of Alzheimer's disease (AD). We previously developed and characterized monoclonal antibodies 31‐2 and 75‐2 that specifically bind to nonfibrillar Aβ1–42 aggregates with diameters of more than 220 and 50 nm, respectively. Here, we report the use of these antibodies to examine the aggregation of exogenous Aβ1–42 in cultured rat hippocampal neurons. From 6 to 24 h after transfection of Aβ1–42, antibody 75‐2 immunolabeled almost all transfected neurons, whereas 31‐2‐positive cells were restricted to a part of the transfected neurons and gradually increased in number. Expression of the F19S/L34P‐mutant Aβ1–42, which showed less of a tendency to aggregate, resulted in clearly reduced immunoreactivity to both antibodies. We also immunohistochemically investigated the temporal cortices of patients with AD and found that 31‐2 preferentially labeled the cores of a subpopulation of large amyloid plaques. The relative number of 31‐2‐immunoreactive plaques was found to correlate with the Braak stages of neurofibrillary tangles, but not with that of amyloid plaques. These results suggest that 31‐2‐reactive Aβ aggregates develop with a delayed time course in cultured neurons and amyloid plaques of AD brains.


  • Open Access

    Apoptosis-inducing factor deficiency decreases the proliferation rate and protects the subventricular zone against ionizing radiation

    by Yoshiaki Sato, Kazuhiro Osato, Tomoyo Ochiishi, Akari Osato, Changlian Zhu, Machiko Sato, Janos Swanpalmer, Nazanine Modjtahedi, Guido Kroemer, Georg H. Kuhn, et al.

  • Open Access

    Apoptosis-inducing factor deficiency decreases the proliferation rate and protects the subventricular zone against ionizing radiation

    by K Osato, Y Sato, T Ochiishi, A Osato, C Zhu, M Sato, J Swanpalmer, N Modjtahedi, G Kroemer, H G Kuhn, et al.

    Cranial radiotherapy in children often leads to progressive cognitive decline. We have established a rodent model of irradiation-induced injury to the young brain. A single dose of 8 Gy was administered to the left hemisphere of postnatal day 10 (P10) mice. Harlequin (Hq) mice, carrying the hypomorphic apoptosis-inducing factor AIFHq mutation, express 60% less AIF at P10 and displayed significantly fewer dying cells in the subventricular zone (SVZ) 6 h after IR, compared with wild type (Wt) littermates. Irradiated cyclophilin A-deficient (CypA−/−) mice confirmed that CypA has an essential role in AIF-induced apoptosis after IR. Hq mice displayed no reduction in SVZ size 7 days after IR, whereas 48% of the SVZ was lost in Wt mice. The proliferation rate was lower in the SVZ of Hq mice. Cultured neural precursor cells from the SVZ of Hq mice displayed a slower proliferation rate and were more resistant to IR. IR preferentially kills proliferating cells, and the slower proliferation rate in the SVZ of Hq mice may, at least partly, explain the protective effect of the Hq mutation. Together, these results indicate that targeting AIF may provide a fruitful strategy for protection of normal brain tissue against the detrimental side effects of IR.